AbbVie Earnings, Revenue beat in Q4 By Investing.com

AbbVie (NYSE:ABBV) reported on Wednesday fourth quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

AbbVie announced earnings per share of $2.92 on revenue of $13.86B. Analysts polled by Investing.com anticipated EPS of $2.85 on revenue of $13.69B.

AbbVie shares are down 3% from the beginning of the year and are trading at $105.12 , down-from-52-week-high.They are under-performing the S&P 500 which is up 1.87% from the start of the year.

AbbVie shares gained 1.59% in pre-market trade the report.

AbbVie follows other major Healthcare sector earnings this month

AbbVie’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.

Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar